Evidence map›Paper›PMID 42724998›Full record

ReviewFrontiers in microbiology2026

Protein aggregation as a bistable switch in bacterial cell fate: from adaptive dormancy to cytotoxic death.

Yuejuan Nong, Weijie Wang, Weiwei Zhu

Abstract readReview
In one paragraph

Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yuejuan NongState Key Laboratory of Vaccines for Infectious Diseases, Xiang-An Biomedicine Laboratory, National Innovation Platform for Industry-Education Integration in Vaccine Research, Department of Laboratory Medicine, School of Public Health, Xiamen University, Xiamen, China.
Weijie WangResearch Center for Clinical Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Weiwei ZhuState Key Laboratory of Vaccines for Infectious Diseases, Xiang-An Biomedicine Laboratory, National Innovation Platform for Industry-Education Integration in Vaccine Research, Department of Laboratory Medicine, School of Public Health, Xiamen University, Xiamen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein aggregation has traditionally been considered a hallmark of proteostasis disruption and cellular dysfunction. However, recent studies have revealed that bacterial protein aggregation is not merely a passive consequence of stress-induced damage but may represent a dynamic component of cellular adaptation. Under adverse conditions, reversible protein condensation and aggregation have been associated with bacterial dormancy, persistence, and the viable but non-culturable (VBNC) state, whereas excessive and irreversible aggregation may contribute to loss of cellular function and bacterial death. Nevertheless, whether protein aggregation serves as a primary determinant of bacterial cell fate or reflects a consequence of broader physiological changes remains an important unresolved question. In this review, we summarize current advances in understanding bacterial protein aggregation, including the roles of liquid-liquid phase separation (LLPS), protein quality control systems, ATP-dependent proteostasis regulation, and aggregate maturation. We discuss how stress-induced alterations in proteostasis networks influence bacterial survival, aging, persistence, and antibiotic tolerance. Available evidence supports a working model whereby the physicochemical properties of protein aggregates may dictate ultimate bacterial cell fate. Nevertheless, the causal link between condensate phase behavior, aggregate material characteristics, and cell fate decisions remains to be thoroughly validated, even though emerging technologies including live single-molecule cell imaging and quantitative analytical tools have greatly advanced our mechanistic understanding of the dynamic progression of bacterial protein aggregation. Finally, we discuss the therapeutic potential and challenges of targeting bacterial proteostasis and aggregation pathways to combat persistent and multidrug-resistant pathogens. A deeper mechanistic understanding of how protein aggregation balances adaptation and toxicity may reveal new vulnerabilities within bacterial survival strategies.

Indexed as

bacterial agingbacterial dormancybacterial proteostasiscell deathprotein aggregationstress response

Identifiers

PMID42724998
PMCPMC13559789

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.